Wall Street Associates’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
TGHSA
ACP
EAM
BC
CC
SCM
ACA
FLAM
GPGA
Wall Street Associates's VCYT Position: Q4 2016 in Review
Wall Street Associates reduced its Veracyte (VCYT) stake by 54% in Q4 2016, selling an estimated $813K and leaving 91,661 shares worth $709K. The position accounts for 0.47% of the portfolio, ranked #77.
Wall Street Associates first reported a position in VCYT in Q4 2013 and has held it in 13 quarters since. The position peaked at $6.51M in Q2 2014. 74 funds tracked by Wall St. Rank hold VCYT as of Q4 2016.
- Wall Street Associates held 91,661 shares of Veracyte worth $709K as of Q4 2016.
- Wall Street Associates sold 108,739 Veracyte shares in Q4 2016, an estimated $813K.
- Veracyte made up 0.47% of Wall Street Associates's portfolio in Q4 2016, its #77 holding.
- Wall Street Associates first reported a position in Veracyte in Q4 2013 and has held it in 13 quarters since.
- Wall Street Associates's Veracyte position peaked at $6.51M in Q2 2014.
- 74 funds tracked by Wall St. Rank held Veracyte as of Q4 2016.
Based on Wall Street Associates's 13F filing for Q4 2016, filed 18 Jan 2017.